Fortis Healthcare Ltd

  • BSE Code : 532843
  • NSE Symbol : FORTIS
  • ISIN : INE061F01013
  • Industry :HEALTHCARE

up-arrow 916.80 5.50(0.60%)

Open Price ()

915.00

Prev. Close ()

911.30

Volume (No’s)

654,971

Market Cap ()

69,214.56

Low Price ()

911.05

High Price ()

920.95

 

Board Meetings

Start Date End Date Purpose
30-Jul-2026 06-Aug-2026 Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve the Un-audited financial results for the quarter ended June 30 2026 The relevant disclosure is attached (As per BSE Announcement dated on: 06.08.2026)
08-Jul-2026 08-Jul-2026 Fortis Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on July 08, 2026 regarding re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Managing Director and Chief Executive Officer).
15-May-2026 22-May-2026 Final Dividend & Audited Results Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve the Audited Financial Results (Standalone and consolidated) for the Quarter and Year Ended March 31, 2026 and recommendation of Final dividend for the Year Ended March 31, 2026. Approval of Financial results for the Quarter and Year Ended March 31, 2026 and Recommendation of Final Dividend for the Year Ended March 31, 2026. (As Per BSE Announcement Dated on: 22/05/2026)
06-Feb-2026 13-Feb-2026 Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and period ended December 31 2025. Outcome Of The Board Meeting-13-02-2026. (As per BSE announcement dated on : 13.02.2026)
04-Nov-2025 11-Nov-2025 Fortis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30 2025. Pursuant to the provisions of Regulation 30, 33, 51(2) and 52 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015 ('SEBI Listing Regulations'), please find attached the outcome of the aboard meeting held today i.e. November 11, 2025 The relevant disclosure is attached (As Per BSE Announcement Dated on 11.11.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew